Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Cash from Financing Activities (2018 - 2025)

Bioadaptives' Cash from Financing Activities history spans 7 years, with the latest figure at $255000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 31.37% to $255000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $549115.0, a 18.8% increase, with the full-year FY2025 number at $555000.0, up 70.14% from a year prior.
  • Cash from Financing Activities hit $255000.0 in Q4 2025 for Bioadaptives, up from $194115.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BDPT hit a ceiling of $255000.0 in Q4 2025 and a floor of $30000.0 in Q3 2021.
  • Historically, Cash from Financing Activities has averaged $93460.5 across 5 years, with a median of $75000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: soared 496.09% in 2021 and later tumbled 57.49% in 2022.
  • Tracing BDPT's Cash from Financing Activities over 5 years: stood at $52000.0 in 2021, then plummeted by 35.81% to $33377.0 in 2022, then skyrocketed by 403.64% to $168100.0 in 2023, then rose by 15.48% to $194115.0 in 2024, then soared by 31.37% to $255000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for BDPT at $255000.0 in Q4 2025, $194115.0 in Q4 2024, and $100000.0 in Q3 2024.